Use of a clobetasol spray formulation to treat psoriasis

Details for Australian Patent Application No. 2006241285 (hide)

Owner Dow Pharmaceutical Sciences Dermalogix Partners, Inc.

Inventors Stewart, Daniel M.; Dow, Gordon J.

Agent Shelston IP

Pub. Number AU-B-2006241285

PCT Pub. Number WO2006/115987

Priority 60/674,946 25.04.05 US

Filing date 20 April 2006

Wipo publication date 2 November 2006

Acceptance publication date 14 April 2011

International Classifications

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61L 9/04 (2006.01) Disinfection, sterilisation or deodorisation of air - using substances evaporated in the air without heating

Event Publications

22 November 2007 PCT application entered the National Phase

  PCT publication WO2006/115987 Priority application(s): WO2006/115987

21 August 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read: Use of a clobetasol spray formulation to treat psoriasis

14 April 2011 Application Accepted

  Published as AU-B-2006241285

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006241287-Blends of gelling and non-gelling starches with gellan gums and plasticizer

2006241282-Method for torque and pitch control for a wind power plant according to the rotational speed